Publisher
Springer International Publishing
Reference69 articles.
1. Barlier A, Jaquet P. Quinagolide – a valuable treatment option for hyperprolactinaemia. Eur J Endocrinol. 2006;154:187–95.
2. Bernard V, Young J, Chanson P, Binart N. New insights in prolactin: pathological implications. Nat Rev Endocrinol. 2015;11(5):265–75.
https://doi.org/10.1038/nrendo.2015.36
. Epub 2015 Mar 17. Review. PMID:25781857
3. Bridges, RS. Prolactin: Regulation and actions. Neuroscience 2018. Online Jan 2018.
https://doi.org/10.1093/acrefore/9780190264086.013.61
.
4. Bronstein MD. Prolactinomas and pregnancy. Pituitary. 2005;8:31–8.
https://doi.org/10.1007/s11102-005-5083-4
.
5. Catli G, Abaci A, Altincik A, Demir K, Can S, Buyukgebiz A, Bober E. Hyperprolactinemia in children: clinical features and long-term results. J Pediatr Endocrinol Metab. 2012;25(11–12):1123–8.